Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 306-657-2 | CAS number: 97358-80-0
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Genetic toxicity: in vitro
Administrative data
- Endpoint:
- in vitro gene mutation study in bacteria
- Remarks:
- Type of genotoxicity: gene mutation
- Type of information:
- migrated information: read-across based on grouping of substances (category approach)
- Adequacy of study:
- weight of evidence
- Study period:
- 18 Oct - 29 Oct 2001
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other: see 'Remark'
- Remarks:
- GLP - Guideline study. According to the ECHA guidance document "Practical guide 6: How to report read-across and categories (March 2010)", the reliability was changed from RL1 to RL2 to reflect the fact that this study was conducted on a read-across substance.
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 004
- Report date:
- 2004
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 471 (Bacterial Reverse Mutation Assay)
- Deviations:
- no
- GLP compliance:
- yes
- Type of assay:
- bacterial reverse mutation assay
Test material
- Reference substance name:
- 736150-63-3
- EC Number:
- 616-005-1
- Cas Number:
- 736150-63-3
- IUPAC Name:
- 736150-63-3
- Details on test material:
- - Name of test material (as cited in study report): only trade name given
- Chemical name: acetic acid esters of monoglyceride of fully hydrogenated castor oil
- Substance type: clear liquid
- Analytical purity: no data
- Lot/batch No.: 10102
- Expiration date of the lot/batch: 26-04-2002
- Item No.: 175540
- Storage condition of test material: at room temperature, protected from light
Constituent 1
Method
- Target gene:
- his operon
Species / strain
- Species / strain / cell type:
- S. typhimurium TA 1535, TA 1537, TA 98, TA 100 and TA 102
- Details on mammalian cell type (if applicable):
- - Type and identity of media:
Liquid growth medium (broth): Oxoid Nutrient Broth No. 2 (2.5% (w/v) in distilled water
Selective agar plates: Vogel-Bonner medium composed of bacto agar (1.5%), D-glucose (2%), MgSO4 x 7H20 (0.02%), citric acid (0.2%), K2HPO4 (1%), NaNH4HPO4 x 4 H2O (0.35%) in distilled water (percentages correspond to w/v)
The components were autoclaved separately and mixed afterwards.
Top-agar: bacto agar (0.6%), NaCl (0.5%) in distilled water (percentages correspond to w/v), supplemented with 0.05 mM histidine and 0.05 mM biotin before use
- Metabolic activation:
- with and without
- Metabolic activation system:
- cofactor supplemented post-mitochondrial fraction (S9 mix), prepared from the livers of rats treated with Aroclor 1254 (500 mg/kg bw)
- Test concentrations with justification for top dose:
- 50, 160, 500, 1600 and 5000 µg/plate
- Vehicle / solvent:
- - Vehicle(s)/solvent(s) used: DMSO
Controlsopen allclose all
- Untreated negative controls:
- no
- Negative solvent / vehicle controls:
- yes
- Remarks:
- DMSO
- True negative controls:
- no
- Positive controls:
- yes
- Positive control substance:
- other: - S9: sodium azide (SA, 1 µg/plate) for TA 100 and TA 1535; 2-nitrofluorene (2NF, 1 µg/plate) for TA 98 and TA 1537; cumene hydroperoxide (CHP, 100 µg/plate for plate incorporation and 25 µg/plate for preincubation) for TA 102;
- Positive control substance:
- other: + S9: 2-aminoanthracene (2-AA, 4 µg/plate for TA 102 or 2 µg/plate for remaining strains)
- Details on test system and experimental conditions:
- METHOD OF APPLICATION:
1. in agar (plate incorporation)
DURATION
- Exposure duration: 72 h
2. preincubation
DURATION
- Preincubation period: 1 h
- Exposure duration: 72 h
NUMBER OF REPLICATIONS: 3 replications each in 2 independent experiments including 1 plate incorporation and 1 preincubation test
DETERMINATION OF CYTOTOXICITY
- Method: other: thinning of the background lawn of non-revertant bacteria, appearance of micro-colonies and/or reduction in the number of revertant colonies on the test plates comparised to the solvent control plates - Evaluation criteria:
- The test was considered to be valid when the following criteria were met:
1. negative and positive control data were consistent and within the range of historical control data (see table 4)
2. positive controls revealed a marked increase over the concurrent solvent controls
3. the evaluation was not restricted by loss of plates (e.g. through contamination)
The test material may be considered mutagenic in this test system if all of the following criteria were met:
1. dose-related increases in the number of revertants at one or more test points
2. reproducible increases in revertants between replicate plates
3. statistically significance in the increases of revertants
4. increases count more than twice the corresponding solvent control values
The test material may be considered non-mutagenic in this test system when no increases in the number of revertants is observed which exceed 1.5 times the solvent control values at any test point. Sporadically ocurring statistically significanct increases in the number of revertants which were not dose-related will usually be considered incidental and not relevant for the evaluation.
Increases between 1.5 and 2 fold compared to the respective solvent controls meeting the other criteria for a positive result were considered to demonstrate weak mutagenicity. - Statistics:
- Statistical analyses were performed with the SAS (R) procedures version 8.1 (SAS Institute Inc., Cary, North Carolina 27513, USA).
In detail, the number of revertant colonies at each treatment test point were compared to the corresponding solvent control values using the Analysis of Variance test. Statistically significant differences were further evaluated via Dunnett´s test to determine the statistical significance of increases and decreases in the number of revertant colonies for each set of triplicates.
Results and discussion
Test results
- Species / strain:
- S. typhimurium TA 1535, TA 1537, TA 98, TA 100 and TA 102
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- other: no but tested up to limit concentrations (a small reduction in the number of revertants was induced in TA 100 (5000 µg: -15% (preincubation assay, +S9) and TA 1535 (160 µg: -28%; 1600 µg: -46%; 5000 µg: -30% (plate incorporation assay, + S9))
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- not examined
- Positive controls validity:
- valid
- Additional information on results:
- RANGE-FINDING/SCREENING STUDIES:
The test item did not induce toxicity within the conducted preliminary toxicity test as evaluated by large reductions in the number of revertants or poor growth of the background lawn of non-revertant bacteria either in the absence or presence of S9 mix (see table 1).
COMPARISON WITH HISTORICAL CONTROL DATA:
The solvent and positive control values were acceptable and compatible with the historical control values (slight increases have been determined in number of revertants for TA 102 in the plate incorporation (-S9: 470 ± 6 vs 409) and preincubation test (+S9: 460 ± 4 vs 432) and for TA 1535 in the plate incorporation assay after treatment with sodium azide (-S9: 1063 ± 83 vs 908), see table 4). - Remarks on result:
- other: all strains/cell types tested
- Remarks:
- Migrated from field 'Test system'.
Any other information on results incl. tables
Table 1. Test results of the preliminary toxicity test (plate incorporation) |
|||
|
|
|
|
With or without S9-Mix |
Test substance concentration |
Mean number of revertant colonies per plate |
|
(μg/plate) |
(average of 3 plates ± Standard Deviation) |
||
|
Frameshift type |
||
|
TA98 |
||
– |
0 |
36.0 ± 1.7 |
|
– |
50 |
30.3 ± 3.1 |
|
– |
160 |
28.7 ± 5.1 |
|
– |
500 |
33.0 ± 6.0 |
|
– |
1600 |
34.3 ± 2.9 |
|
– |
5000 |
34.3 ± 7.0 |
|
Positive controls, –S9 |
Name |
2NF |
|
Concentrations (μg/plate) |
1 |
||
Mean No. of colonies/plate (average of 3 ± SD) |
499.7 ± 88.3 |
||
+ |
0 |
48 ± 3 |
|
+ |
50 |
48.3 ± 5.5 |
|
+ |
160 |
43.3 ± 2.9 |
|
+ |
500 |
40.0 ± 6.6 |
|
+ |
1600 |
40.0 ± 1.0 |
|
+ |
5000 |
39.7 ± 6.1 |
|
Positive controls, +S9 |
Name |
2AA |
|
Concentrations (μg/plate) |
2 |
||
Mean No. of colonies/plate (average of 3 ± SD) |
682 ± 26.5 |
||
2NF = 2 Nitrofluorene |
|
|
|
2AA = 2-Aminoanthracene |
|
|
|
No statistical analysis was performed. |
|
Table 2. Test results of main test 1 (plate incorporation) |
|
|
|
||||
|
|
|
|
|
|
|
|
With or without S9-Mix |
Test substance concentration |
Mean number of revertant colonies per plate |
|||||
(μg/plate) |
(average of 3 plates ± Standard deviation) |
||||||
|
Base-pair substitution type |
Frameshift type |
|||||
|
TA 100 |
TA1535 |
TA102 |
TA98 |
TA1537 |
||
– |
0 |
210.3 ± 7.5 |
14.7 ± 1.5 |
469.7 ± 6.1 |
30.7 ± 7.6 |
14.0 ± 2.0 |
|
– |
50 |
210.7 ± 7.8 |
15.7 ± 2.5 |
474.0 ± 3.0 |
33.3 ± 7.2 |
17.7 ± 2.5 |
|
– |
160 |
206.0 ± 5.3 |
15.0 ± 1.0 |
480.0 ± 6.6 |
27.7 ± 0.6 |
18.0 ± 2.0 |
|
– |
500 |
205.7 ± 3.8 |
16.3 ± 2.1 |
478.7 ± 5.7 |
27.0 ± 2.6 |
15.0 ± 2.0 |
|
– |
1600 |
208.7 ± 9.3 |
15.0 ± 3.6 |
479.0 ± 6.2 |
26.0 ± 5.0 |
16.3 ± 2.3 |
|
– |
5000 |
208.3 ± 2.9 |
12.3 ± 1.5 |
483.7 ± 5.5 |
32.7 ± 3.1 |
15.7 ± 2.5 |
|
Positive controls, –S9 |
Name |
SA |
SA |
CHP |
2NF |
2NF |
|
Concentrations (μg/plate) |
1 |
1 |
100 |
1 |
1 |
||
Mean No. of colonies/plate (average of 3 ± SD) |
1136.7 ± 60.8 |
1063 ± 82.5 |
968.3 ± 78.4 |
749.7 ± 100.5 |
202.0 ± 7.9 |
||
+ |
0 |
213.7 ± 3.8 |
20.3 ± 2.9 |
405.3 ± 1.5 |
43.3 ± 2.1 |
16.7 ± 1.5 |
|
+ |
50 |
213.3 ± 3.1 |
19.0 ± 1.0 |
399.7 ± 6.8 |
41.0 ± 2.0 |
20.3 ± 0.6 |
|
+ |
160 |
215.7 ± 3.8 |
14.7* ± 1.5 |
401.3 ± 10.2 |
44.0 ± 2.0 |
19.7 ± 0.6 |
|
+ |
500 |
202.0 ± 5.3 |
17.0 ± 2.6 |
405.0 ± 11.5 |
40.3 ± 2.5 |
18.7 ± 0.6 |
|
+ |
1600 |
208.0 ± 11.1 |
11.0 ± 1.7 |
406.7 ± 9.7 |
42.0 ± 3.6 |
18.7 ± 2.1 |
|
+ |
5000 |
216.7 ± 4.2 |
14.3* ± 3.1 |
405.7 ± 4.7 |
43.0 ± 1.7 |
19.0 ± 1.7 |
|
Positive controls, +S9 |
Name |
2AA |
2AA |
2AA |
2AA |
2AA |
|
Concentrations (μg/plate) |
2 |
2 |
4 |
2 |
2 |
||
Mean No. of colonies/plate (average of 3 ± SD) |
838.0 ± 71.4 |
276.0 ± 80.0 |
1030.3 ± 102.6 |
597.0 ± 25.6 |
366.7 ± 34.0 |
||
SA = sodium azide |
|
|
|
|
|
||
CHP = cumene hydroperoxide |
|
|
|
|
|
||
2NF = 2-nitrofluorene |
|
|
|
|
|
||
2AA = 2-Aminoanthracene |
|
|
|
|
|
||
* = statistically significant at 5% level |
|
|
|
|
|||
* * = statistically significant at 1% level |
|
|
|
|
|||
Otherwise not statistically significant at 5% level (positive controls were not included) |
|
Table 3. Test results of main test 2 (preincubation) |
|
|
|
||||
|
|
|
|
|
|
|
|
With or without S9-Mix |
Test substance concentration |
Mean number of revertant colonies per plate |
|||||
(μg/plate) |
(average of 3 plates ± Standard deviation) |
||||||
|
Base-pair substitution type |
Frameshift type |
|||||
|
TA 100 |
TA1535 |
TA102 |
TA98 |
TA1537 |
||
– |
0 |
214.7 ± 4.0 |
18.0 ± 3.0 |
403.7 ± 3.1 |
36.0 ± 1.7 |
15.7 ± 1.2 |
|
– |
50 |
213.3 ± 6.4 |
17.3± 0.6 |
405.0 ± 5.6 |
30.3 ± 3.1 |
18.3 ± 0.6 |
|
– |
160 |
213.7 ± 6.0 |
18.3 ± 3.5 |
407.7 ± 2.3 |
28.7 ± 5.1 |
18.3 ± 1.5 |
|
– |
500 |
213.0 ± 1.7 |
21.3 ± 4.2 |
403.7 ± 1.5 |
33.0 ± 6.0 |
19.0 ± 1.0 |
|
– |
1600 |
211.0 ± 11.5 |
21.3 ± 3.2 |
406.7 ± 4.9 |
34.3 ± 2.9 |
18.3 ± 2.1 |
|
– |
5000 |
212.3 ± 6.5 |
17.0 ± 1.7 |
411.3 ± 13.7 |
34.3 ± 7.0 |
17.0 ± 1.0 |
|
Positive controls, –S9 |
Name |
SA |
SA |
CHP |
2NF |
2NF |
|
Concentrations (μg/plate) |
1 |
1 |
25 |
1 |
1 |
||
Mean No. of colonies/plate (average of 3 ± SD) |
1103.0 ± 25.5 |
596.3 ± 25.5 |
1158.0 ± 33.2 |
499.7 ± 88.3 |
338.7± 22.7 |
||
+ |
0 |
203.7 ± 7.5 |
11.7 ± 1.2 |
459.7 ± 4.2 |
48.0 ± 3.0 |
18.7 ± 1.2 |
|
+ |
50 |
206.0 ± 12.2 |
17.0 ± 1.0 |
460.0 ± 2.6 |
48.3 ± 5.5 |
20.0 ± 1.0 |
|
+ |
160 |
213.7 ± 4.7 |
16.3 ± 4.2 |
456.7 ± 4.5 |
43.3 ± 2.9 |
19.0 ± 1.0 |
|
+ |
500 |
207.7 ± 6.8 |
15.7 ± 2.1 |
455.3 ± 3.8 |
40.0 ± 6.6 |
18.0 ± 1.7 |
|
+ |
1600 |
188.7 ± 3.1 |
15.0 ± 4.0 |
458.3 ± 2.5 |
40.0 ± 1.0 |
19.0 ± 1.0 |
|
+ |
5000 |
173.3** ± 9.5 |
17.7 ± 2.3 |
459.7 ± 4.2 |
39.7 ± 6.1 |
19.0 ± 1.0 |
|
Positive controls, +S9 |
Name |
2AA |
2AA |
2AA |
2AA |
2AA |
|
Concentrations (μg/plate) |
2 |
2 |
4 |
2 |
2 |
||
Mean No. of colonies/plate (average of 3 ± SD) |
574.7 ± 30.2 |
231.7 ± 18.9 |
1140.7 ± 98.8 |
682.0 ± 26.5 |
210.3 ± 16.0 |
||
SA = sodium azide |
|
|
|
|
|
||
CH = cumene hydroperoxide |
|
|
|
|
|
||
2NF = 2-nitrofluorene |
|
|
|
|
|
||
2AA = 2-Aminoanthracene |
|
|
|
|
|
||
* = statistically significant at 5% level |
|
|
|
|
|||
* * = statistically significant at 1% level |
|
|
|
|
|||
Otherwise not statistically significant at 5% level (positive controls were not included) |
|
Table 4. Historical control values |
|
|
|
|
|
|||
|
|
|
|
|
|
|
|
|
Strain |
Treatment (µg/mL) |
S9 mix |
Number of revertant colonies/plate |
Number of plates |
||||
Mean |
Standard Deviation |
Minimum |
Maximum |
|
||||
TA 102 |
solvent |
- |
305 |
40 |
249 |
409 |
114 |
|
|
solvent |
+ |
321 |
52 |
224 |
432 |
117 |
|
|
CHP (25) |
- |
1262 |
346 |
836 |
2487 |
54 |
|
|
CHP (100) |
- |
1252 |
258 |
903 |
2000 |
48 |
|
|
2AA (4) |
+ |
1076 |
197 |
500 |
1522 |
105 |
|
TA 100 |
solvent |
- |
144 |
33 |
91 |
221 |
162 |
|
|
solvent |
+ |
143 |
35 |
90 |
234 |
168 |
|
|
SA (1) |
- |
1006 |
196 |
578 |
1460 |
150 |
|
|
2AA (2) |
+ |
1007 |
362 |
123 |
2163 |
156 |
|
TA 98 |
solvent |
- |
51 |
16 |
19 |
82 |
159 |
|
|
solvent |
+ |
61 |
17 |
21 |
97 |
162 |
|
|
2NF (1) |
- |
658 |
247 |
216 |
1189 |
147 |
|
|
2AA (2) |
+ |
851 |
284 |
411 |
1622 |
150 |
|
TA 1537 |
solvent |
- |
15 |
5 |
5 |
28 |
111 |
|
|
solvent |
+ |
19 |
7 |
7 |
43 |
117 |
|
|
2NF (1) |
- |
357 |
154 |
121 |
919 |
99 |
|
|
2AA (2) |
+ |
301 |
202 |
67 |
1121 |
105 |
|
TA 1535 |
solvent |
- |
20 |
8 |
7 |
38 |
117 |
|
|
solvent |
+ |
18 |
7 |
7 |
42 |
123 |
|
|
SA (1) |
- |
541 |
169 |
206 |
908 |
105 |
|
|
2AA (2) |
+ |
272 |
129 |
110 |
648 |
111 |
|
SA = sodium azide |
|
|||||||
CHP = cumene hydroperoxide |
|
|||||||
2NF = 2-nitrofluorene |
|
|||||||
2AA = 2-Aminoanthracene |
|
Applicant's summary and conclusion
- Conclusions:
- Interpretation of results (migrated information):
negative
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.